The global Healthcare Contract Research Organizations (CRO) Services market size was valued at USD 66880 million in 2023 and is forecast to a readjusted size of USD 116630 million by 2030 with a CAGR of 8.3% during review period.
Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The publisher report includes an overview of the development of the Healthcare Contract Research Organizations (CRO) Services industry chain, the market status of Medical Device Companies (Preclinical CROs, Clinical CROs), Pharmaceutical and Biopharmaceutical Companies (Preclinical CROs, Clinical CROs), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Healthcare Contract Research Organizations (CRO) Services.
Regionally, the report analyzes the Healthcare Contract Research Organizations (CRO) Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Healthcare Contract Research Organizations (CRO) Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Healthcare Contract Research Organizations (CRO) Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Healthcare Contract Research Organizations (CRO) Services industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Preclinical CROs, Clinical CROs).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Healthcare Contract Research Organizations (CRO) Services market.
Regional Analysis: The report involves examining the Healthcare Contract Research Organizations (CRO) Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Healthcare Contract Research Organizations (CRO) Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Healthcare Contract Research Organizations (CRO) Services:
Company Analysis: Report covers individual Healthcare Contract Research Organizations (CRO) Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Healthcare Contract Research Organizations (CRO) Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Medical Device Companies, Pharmaceutical and Biopharmaceutical Companies).
Technology Analysis: Report covers specific technologies relevant to Healthcare Contract Research Organizations (CRO) Services. It assesses the current state, advancements, and potential future developments in Healthcare Contract Research Organizations (CRO) Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Healthcare Contract Research Organizations (CRO) Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Healthcare Contract Research Organizations (CRO) Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Preclinical CROs
Clinical CROs
Consulting Services
Clinical Research Services
麻豆原创 segment by Application
Medical Device Companies
Pharmaceutical and Biopharmaceutical Companies
Others
麻豆原创 segment by players, this report covers
IQVIA
ICON (Incl. PRA)
Labcorp
Syneos Health
PPD (Thermo Fisher)
Medpace
Parexel
Wuxi Apptec
Charles River
Pharmaron
EPS International
Worldwide Clinical Trials
CMIC
Inotiv
JOINN Lab
ChemPartner
Medicilon
EVOTEC
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Healthcare Contract Research Organizations (CRO) Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Healthcare Contract Research Organizations (CRO) Services, with revenue, gross margin and global market share of Healthcare Contract Research Organizations (CRO) Services from 2019 to 2024.
Chapter 3, the Healthcare Contract Research Organizations (CRO) Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Healthcare Contract Research Organizations (CRO) Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Healthcare Contract Research Organizations (CRO) Services.
Chapter 13, to describe Healthcare Contract Research Organizations (CRO) Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope of Healthcare Contract Research Organizations (CRO) Services
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Healthcare Contract Research Organizations (CRO) Services by Type
1.3.1 Overview: Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Healthcare Contract Research Organizations (CRO) Services Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Preclinical CROs
1.3.4 Clinical CROs
1.3.5 Consulting Services
1.3.6 Clinical Research Services
1.4 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 by Application
1.4.1 Overview: Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Medical Device Companies
1.4.3 Pharmaceutical and Biopharmaceutical Companies
1.4.4 Others
1.5 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size & Forecast
1.6 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast by Region
1.6.1 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 IQVIA
2.1.1 IQVIA Details
2.1.2 IQVIA Major Business
2.1.3 IQVIA Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.1.4 IQVIA Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 IQVIA Recent Developments and Future Plans
2.2 ICON (Incl. PRA)
2.2.1 ICON (Incl. PRA) Details
2.2.2 ICON (Incl. PRA) Major Business
2.2.3 ICON (Incl. PRA) Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.2.4 ICON (Incl. PRA) Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 ICON (Incl. PRA) Recent Developments and Future Plans
2.3 Labcorp
2.3.1 Labcorp Details
2.3.2 Labcorp Major Business
2.3.3 Labcorp Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.3.4 Labcorp Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Labcorp Recent Developments and Future Plans
2.4 Syneos Health
2.4.1 Syneos Health Details
2.4.2 Syneos Health Major Business
2.4.3 Syneos Health Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.4.4 Syneos Health Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Syneos Health Recent Developments and Future Plans
2.5 PPD (Thermo Fisher)
2.5.1 PPD (Thermo Fisher) Details
2.5.2 PPD (Thermo Fisher) Major Business
2.5.3 PPD (Thermo Fisher) Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.5.4 PPD (Thermo Fisher) Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 PPD (Thermo Fisher) Recent Developments and Future Plans
2.6 Medpace
2.6.1 Medpace Details
2.6.2 Medpace Major Business
2.6.3 Medpace Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.6.4 Medpace Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Medpace Recent Developments and Future Plans
2.7 Parexel
2.7.1 Parexel Details
2.7.2 Parexel Major Business
2.7.3 Parexel Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.7.4 Parexel Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Parexel Recent Developments and Future Plans
2.8 Wuxi Apptec
2.8.1 Wuxi Apptec Details
2.8.2 Wuxi Apptec Major Business
2.8.3 Wuxi Apptec Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.8.4 Wuxi Apptec Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Wuxi Apptec Recent Developments and Future Plans
2.9 Charles River
2.9.1 Charles River Details
2.9.2 Charles River Major Business
2.9.3 Charles River Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.9.4 Charles River Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Charles River Recent Developments and Future Plans
2.10 Pharmaron
2.10.1 Pharmaron Details
2.10.2 Pharmaron Major Business
2.10.3 Pharmaron Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.10.4 Pharmaron Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Pharmaron Recent Developments and Future Plans
2.11 EPS International
2.11.1 EPS International Details
2.11.2 EPS International Major Business
2.11.3 EPS International Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.11.4 EPS International Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 EPS International Recent Developments and Future Plans
2.12 Worldwide Clinical Trials
2.12.1 Worldwide Clinical Trials Details
2.12.2 Worldwide Clinical Trials Major Business
2.12.3 Worldwide Clinical Trials Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.12.4 Worldwide Clinical Trials Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Worldwide Clinical Trials Recent Developments and Future Plans
2.13 CMIC
2.13.1 CMIC Details
2.13.2 CMIC Major Business
2.13.3 CMIC Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.13.4 CMIC Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 CMIC Recent Developments and Future Plans
2.14 Inotiv
2.14.1 Inotiv Details
2.14.2 Inotiv Major Business
2.14.3 Inotiv Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.14.4 Inotiv Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.14.5 Inotiv Recent Developments and Future Plans
2.15 JOINN Lab
2.15.1 JOINN Lab Details
2.15.2 JOINN Lab Major Business
2.15.3 JOINN Lab Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.15.4 JOINN Lab Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.15.5 JOINN Lab Recent Developments and Future Plans
2.16 ChemPartner
2.16.1 ChemPartner Details
2.16.2 ChemPartner Major Business
2.16.3 ChemPartner Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.16.4 ChemPartner Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.16.5 ChemPartner Recent Developments and Future Plans
2.17 Medicilon
2.17.1 Medicilon Details
2.17.2 Medicilon Major Business
2.17.3 Medicilon Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.17.4 Medicilon Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.17.5 Medicilon Recent Developments and Future Plans
2.18 EVOTEC
2.18.1 EVOTEC Details
2.18.2 EVOTEC Major Business
2.18.3 EVOTEC Healthcare Contract Research Organizations (CRO) Services Product and Solutions
2.18.4 EVOTEC Healthcare Contract Research Organizations (CRO) Services Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.18.5 EVOTEC Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Healthcare Contract Research Organizations (CRO) Services Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Healthcare Contract Research Organizations (CRO) Services by Company Revenue
3.2.2 Top 3 Healthcare Contract Research Organizations (CRO) Services Players 麻豆原创 Share in 2023
3.2.3 Top 6 Healthcare Contract Research Organizations (CRO) Services Players 麻豆原创 Share in 2023
3.3 Healthcare Contract Research Organizations (CRO) Services 麻豆原创: Overall Company Footprint Analysis
3.3.1 Healthcare Contract Research Organizations (CRO) Services 麻豆原创: Region Footprint
3.3.2 Healthcare Contract Research Organizations (CRO) Services 麻豆原创: Company Product Type Footprint
3.3.3 Healthcare Contract Research Organizations (CRO) Services 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Healthcare Contract Research Organizations (CRO) Services Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Healthcare Contract Research Organizations (CRO) Services Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Healthcare Contract Research Organizations (CRO) Services Consumption Value by Type (2019-2030)
6.2 North America Healthcare Contract Research Organizations (CRO) Services Consumption Value by Application (2019-2030)
6.3 North America Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Country
6.3.1 North America Healthcare Contract Research Organizations (CRO) Services Consumption Value by Country (2019-2030)
6.3.2 United States Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Healthcare Contract Research Organizations (CRO) Services Consumption Value by Type (2019-2030)
7.2 Europe Healthcare Contract Research Organizations (CRO) Services Consumption Value by Application (2019-2030)
7.3 Europe Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Country
7.3.1 Europe Healthcare Contract Research Organizations (CRO) Services Consumption Value by Country (2019-2030)
7.3.2 Germany Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Healthcare Contract Research Organizations (CRO) Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Healthcare Contract Research Organizations (CRO) Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Region
8.3.1 Asia-Pacific Healthcare Contract Research Organizations (CRO) Services Consumption Value by Region (2019-2030)
8.3.2 China Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Healthcare Contract Research Organizations (CRO) Services Consumption Value by Type (2019-2030)
9.2 South America Healthcare Contract Research Organizations (CRO) Services Consumption Value by Application (2019-2030)
9.3 South America Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Country
9.3.1 South America Healthcare Contract Research Organizations (CRO) Services Consumption Value by Country (2019-2030)
9.3.2 Brazil Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Healthcare Contract Research Organizations (CRO) Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Healthcare Contract Research Organizations (CRO) Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size by Country
10.3.1 Middle East & Africa Healthcare Contract Research Organizations (CRO) Services Consumption Value by Country (2019-2030)
10.3.2 Turkey Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Drivers
11.2 Healthcare Contract Research Organizations (CRO) Services 麻豆原创 Restraints
11.3 Healthcare Contract Research Organizations (CRO) Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Healthcare Contract Research Organizations (CRO) Services Industry Chain
12.2 Healthcare Contract Research Organizations (CRO) Services Upstream Analysis
12.3 Healthcare Contract Research Organizations (CRO) Services Midstream Analysis
12.4 Healthcare Contract Research Organizations (CRO) Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
IQVIA
ICON (Incl. PRA)
Labcorp
Syneos Health
PPD (Thermo Fisher)
Medpace
Parexel
Wuxi Apptec
Charles River
Pharmaron
EPS International
Worldwide Clinical Trials
CMIC
Inotiv
JOINN Lab
ChemPartner
Medicilon
EVOTEC
听
听
*If Applicable.
